GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hoechst Pakistan Ltd (KAR:HPL) » Definitions » Price-to-Owner-Earnings

Hoechst Pakistan (KAR:HPL) Price-to-Owner-Earnings : 6.28 (As of May. 17, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Hoechst Pakistan Price-to-Owner-Earnings?

As of today (2024-05-17), Hoechst Pakistan's share price is ₨1434.05. Hoechst Pakistan's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₨228.47. It's Price-to-Owner-Earnings for today is 6.28.


The historical rank and industry rank for Hoechst Pakistan's Price-to-Owner-Earnings or its related term are showing as below:

KAR:HPL' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.11   Med: 9.67   Max: 182.04
Current: 6.48

During the past 13 years, the highest Price-to-Owner-Earnings of Hoechst Pakistan was 182.04. The lowest was 4.11. And the median was 9.67.


KAR:HPL's Price-to-Owner-Earnings is ranked better than
92.86% of 420 companies
in the Drug Manufacturers industry
Industry Median: 28.16 vs KAR:HPL: 6.48

As of today (2024-05-17), Hoechst Pakistan's share price is ₨1434.05. Hoechst Pakistan's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₨109.26. Therefore, Hoechst Pakistan's PE Ratio for today is 13.13.

As of today (2024-05-17), Hoechst Pakistan's share price is ₨1434.05. Hoechst Pakistan's EPS without NRI for the trailing twelve months (TTM) ended in was ₨109.26. Therefore, Hoechst Pakistan's PE Ratio without NRI for today is 13.13.

During the past 13 years, Hoechst Pakistan's highest PE Ratio without NRI was 97.24. The lowest was 5.80. And the median was 19.85.


Hoechst Pakistan Price-to-Owner-Earnings Historical Data

The historical data trend for Hoechst Pakistan's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hoechst Pakistan Price-to-Owner-Earnings Chart

Hoechst Pakistan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 9.18 - 5.38

Hoechst Pakistan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.54 5.25 5.38 5.69

Competitive Comparison of Hoechst Pakistan's Price-to-Owner-Earnings

For the Drug Manufacturers - General subindustry, Hoechst Pakistan's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hoechst Pakistan's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Hoechst Pakistan's Price-to-Owner-Earnings falls into.



Hoechst Pakistan Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Hoechst Pakistan's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1434.05/228.47
=6.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hoechst Pakistan  (KAR:HPL) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Hoechst Pakistan Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Hoechst Pakistan's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Hoechst Pakistan (KAR:HPL) Business Description

Traded in Other Exchanges
N/A
Address
Korangi Industrial Area, Plot 23, Sector 22, Karachi, PAK, 74900
Hoechst Pakistan Ltd Formerly Sanofi-Aventis Pakistan Ltd is engaged in the manufacturing and selling of pharmaceutical and consumer healthcare products and vaccines. Its product profile includes Oral Anti-Diabetics, Emergency Care, Antibiotics, Anti-malaria, Epilepsy, Sleep Disorders, and others. Geographically, the company operates in Pakistan, Afghanistan, and others.

Hoechst Pakistan (KAR:HPL) Headlines

No Headlines